121 related articles for article (PubMed ID: 33068832)
1. VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway.
Wang X; Liang C; Xia W; Guo C; Niu Z; Zhu W; Zhang H
Mol Immunol; 2020 Dec; 128():41-46. PubMed ID: 33068832
[TBL] [Abstract][Full Text] [Related]
2. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
Ganta VC; Choi M; Kutateladze A; Annex BH
Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
[TBL] [Abstract][Full Text] [Related]
3. VEGF
Boudria A; Abou Faycal C; Jia T; Gout S; Keramidas M; Didier C; Lemaître N; Manet S; Coll JL; Toffart AC; Moro-Sibilot D; Albiges-Rizo C; Josserand V; Faurobert E; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2019 Feb; 38(7):1050-1066. PubMed ID: 30194450
[TBL] [Abstract][Full Text] [Related]
4. A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF
Chu LH; Ganta VC; Choi MH; Chen G; Finley SD; Annex BH; Popel AS
Sci Rep; 2016 Nov; 6():37030. PubMed ID: 27853189
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway.
Althaus J; Nilius-Eliliwi V; Maghnouj A; Döring S; Schroers R; Hudecek M; Hahn SA; Mika T
Cancer Immunol Immunother; 2023 Aug; 72(8):2573-2583. PubMed ID: 37052701
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic VEGF
Ganta VC; Choi M; Farber CR; Annex BH
Circulation; 2019 Jan; 139(2):226-242. PubMed ID: 30586702
[TBL] [Abstract][Full Text] [Related]
7. Targeting Anti-Angiogenic VEGF
Kuppuswamy S; Annex BH; Ganta VC
Cells; 2022 Aug; 11(17):. PubMed ID: 36078086
[TBL] [Abstract][Full Text] [Related]
8. VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis.
Gu F; Li X; Kong J; Pan B; Sun M; Zheng L; Yao Y
Biochem Biophys Res Commun; 2013 Nov; 441(1):18-24. PubMed ID: 24125722
[TBL] [Abstract][Full Text] [Related]
9. VEGF165b mutant with a prolonged half-life and enhanced anti-tumor potency in a mouse model.
Zhang H; Jia E; Xia W; Lu C; Zhu W
J Biotechnol; 2018 Oct; 284():84-90. PubMed ID: 30134149
[TBL] [Abstract][Full Text] [Related]
10. [Construction of NKG2D CAR-NK92 cells and its killing effect on multiple myeloma cells].
Long J; Zheng R; Ye S; Ke S; Duan D; Wei C; Gao J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):577-585. PubMed ID: 37403715
[TBL] [Abstract][Full Text] [Related]
11. Influence of reverse signaling via membrane TNF-alpha on cytotoxicity of NK92 cells.
Yu M; Shi W; Zhang J; Niu L; Chen Q; Yan D; Liu T; Jing W; Jiang X; Wei F; Yin B; Zhang W; Li Q; Li Z
Eur J Cell Biol; 2009 Mar; 88(3):181-91. PubMed ID: 18950896
[TBL] [Abstract][Full Text] [Related]
12. Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B.
Wroblewski M; Bauer R; Cubas Córdova M; Udonta F; Ben-Batalla I; Legler K; Hauser C; Egberts J; Janning M; Velthaus J; Schulze C; Pantel K; Bokemeyer C; Loges S
Nat Commun; 2017 Aug; 8(1):269. PubMed ID: 28814715
[TBL] [Abstract][Full Text] [Related]
13. Effects of total flavonoids of sea buckthorn ( Hippophae rhamnoides L.) on cytotoxicity of NK92-MI cells.
Hou D; Wang D; Ma X; Chen W; Guo S; Guan H
Int J Immunopathol Pharmacol; 2017 Dec; 30(4):353-361. PubMed ID: 28994628
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological implications of vascular endothelial growth factor 165b expression in oral squamous cell carcinoma stroma.
Nagasaki M; Kondo S; Mukudai Y; Kamatani T; Akizuki A; Yaso A; Shimane T; Shirota T
Oncol Rep; 2016 Jul; 36(1):573-81. PubMed ID: 27221145
[TBL] [Abstract][Full Text] [Related]
15. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
Rennel E; Waine E; Guan H; Schüler Y; Leenders W; Woolard J; Sugiono M; Gillatt D; Kleinerman E; Bates D; Harper S
Br J Cancer; 2008 Apr; 98(7):1250-7. PubMed ID: 18349828
[TBL] [Abstract][Full Text] [Related]
16. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
17. VEGF165b and its mutant demonstrate immunomodulatory, not merely anti-angiogenic functions, in tumor-bearing mice.
Zhang H; Xia W; Liang C; Wang X; Zhi L; Guo C; Niu Z; Zhu W
Mol Immunol; 2020 Apr; 122():132-140. PubMed ID: 32353584
[TBL] [Abstract][Full Text] [Related]
18. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
19. Systems Pharmacology of VEGF165b in Peripheral Artery Disease.
Clegg LE; Ganta VC; Annex BH; Mac Gabhann F
CPT Pharmacometrics Syst Pharmacol; 2017 Dec; 6(12):833-844. PubMed ID: 29193887
[TBL] [Abstract][Full Text] [Related]
20. Granzyme B and perforin produced by SEC2 mutant-activated human CD4
Zhang G; Zheng G; Jiang F; Wu T; Wu L
Int J Biol Macromol; 2021 Nov; 190():284-290. PubMed ID: 34492245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
